From Science to Commercial Growth
We translate complex scientific breakthroughs into tangible commercial value. Our firm bridges the gap between laboratory innovation and the global marketplace, ensuring that precision oncology and molecular diagnostics reach the patients who need them most.
By leveraging deep expertise in genomics and MedTech, we provide the strategic leadership required for international expansion. We help life science companies navigate the complexities of market entry and build high-performing commercial channels across Europe, the Middle East, and LATAM.
Core Services
Strategic advisory for life science commercialization across global markets.
Precision Oncology
Liquid Biopsy
Bioinformatics
Companion Diagnostics
MedTech
Molecular Diagnostics
Genomics
Global Reach
We operate across Europe, the Middle East, Latin America, North America, and the Asia-Pacific, providing the international commercial infrastructure required for life science companies to scale globally.
Selected Impact
Strategic commercial outcomes for life science companies expanding across global markets.
Market Expansion
Successfully facilitated entry into the European and Middle Eastern markets for a precision oncology diagnostic portfolio.
Commercial Strategy
Developed a comprehensive commercial roadmap for a global NGS business, resulting in a 40% increase in international revenue.
Business Development
Established a high-performing commercial channel in the LATAM region, accelerating market penetration for a liquid biopsy platform.
Strategic Partnerships
Secured a landmark international partnership for a companion diagnostics business, driving significant value across APAC and Europe.
Market Intelligence
Delivered actionable market intelligence for a MedTech firm, enabling a successful commercialization strategy in North America.
Led by Daniel Giner
Daniel Giner is a globally recognized leader in life sciences commercialization, with a career defined by the successful expansion of precision oncology and molecular diagnostics across international markets. His leadership at Genomic Insights International is anchored in a deep understanding of the commercial dynamics of the global life science industry, providing the strategic direction required for high-growth companies to navigate complex regulatory landscapes and build high-performing commercial channels.
Founders
Early-stage innovators seeking to scale their precision oncology and diagnostics platforms into global markets.
CCOs
Senior leaders focused on commercializing complex genomics and NGS technologies with a global commercial strategy.
Investors
PE/VC portfolio companies and institutional investors looking to accelerate the commercialization of their life-science assets.
Global Firms
International life-science companies expanding across Europe, the Middle East, Latin America, and the Asia-Pacific region.